ConductScience.org, home
Safety and Efficacy Study of LUM001 (Maralixibat) With a Drug Withdrawal Period in Participants With Alagille Syndrome (ALGS)
API referenceFor AI assistants

Trial · NCT02160782

Participant flow60

How many started, completed or left each group, period by period.

41 to 60 of 60

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
After Randomized Withdrawal: MaralixibatNOT COMPLETEDOpen-label Period: Maralixibat (LUM001)0
After Randomized Withdrawal: MaralixibatNOT COMPLETEDRandomized Withdrawal Period: MRX0
After Randomized Withdrawal: MaralixibatNOT COMPLETEDRandomized Withdrawal Period: Placebo0
After Randomized Withdrawal: MaralixibatNOT COMPLETEDAfter Randomized Withdrawal Period: Maralixibat6
After Randomized Withdrawal: MaralixibatNOT COMPLETEDLong-term Extension Period: Maralixibat0
Long-term Extension Period: MaralixibatSTARTEDOpen-label Period: Maralixibat (LUM001)0
Long-term Extension Period: MaralixibatSTARTEDRandomized Withdrawal Period: MRX0
Long-term Extension Period: MaralixibatSTARTEDRandomized Withdrawal Period: Placebo0
Long-term Extension Period: MaralixibatSTARTEDAfter Randomized Withdrawal Period: Maralixibat0
Long-term Extension Period: MaralixibatSTARTEDLong-term Extension Period: Maralixibat23
Long-term Extension Period: MaralixibatCOMPLETEDOpen-label Period: Maralixibat (LUM001)0
Long-term Extension Period: MaralixibatCOMPLETEDRandomized Withdrawal Period: MRX0
Long-term Extension Period: MaralixibatCOMPLETEDRandomized Withdrawal Period: Placebo0
Long-term Extension Period: MaralixibatCOMPLETEDAfter Randomized Withdrawal Period: Maralixibat0
Long-term Extension Period: MaralixibatCOMPLETEDLong-term Extension Period: Maralixibat14
Long-term Extension Period: MaralixibatNOT COMPLETEDOpen-label Period: Maralixibat (LUM001)0
Long-term Extension Period: MaralixibatNOT COMPLETEDRandomized Withdrawal Period: MRX0
Long-term Extension Period: MaralixibatNOT COMPLETEDRandomized Withdrawal Period: Placebo0
Long-term Extension Period: MaralixibatNOT COMPLETEDAfter Randomized Withdrawal Period: Maralixibat0
Long-term Extension Period: MaralixibatNOT COMPLETEDLong-term Extension Period: Maralixibat9

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02160782/flow?page=3

API referenceFor AI assistants